Back
AstraZeneca PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Buy
70
AZNCF
AstraZeneca PLC
Last Price:
154.61
Seasonality Move:
3.63%
Sell
49
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
1.27
Seasonality Move:
-17.41%
Buy
70
AstraZeneca PLC (AZNCF)
is a Buy
Is AstraZeneca PLC a Buy, Sell or Hold?
- The current AstraZeneca PLC [AZNCF] share price is $154.61. The Score for AZNCF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- AZNCF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $1.27. The Score for BDRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AZNCF Stock Price Chart
What is AstraZeneca PLC's stock price today?
-
The AstraZeneca PLC share price today is $154.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AZNCF is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $1.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing slight buying pressure.
AZNCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.4 | Buy |
| Relative Strength Index (14 RSI): | 62.02 | Buy |
| Chaikin Money Flow: | 445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.66 - 154.48) | Buy |
| Bollinger Bands (100): | (127.68 - 144.36) | Buy |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 57.92 | Buy |
| Chaikin Money Flow: | 70043 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.83 - 1.25) | Buy |
| Bollinger Bands (100): | (0.93 - 1.91) | Sell |
AZNCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.46 | Buy |
| 20-day SMA: | 150.04 | Buy |
| 50-day SMA: | 140.75 | Buy |
| 200-day SMA: | 133.86 | Buy |
| 8-day EMA: | 153.82 | Buy |
| 20-day EMA: | 150 | Buy |
| 50-day EMA: | 143.16 | Buy |
| 200-day EMA: | 135.98 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Buy |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.07 | Buy |
| 200-day SMA: | 2.87 | Sell |
| 8-day EMA: | 1.15 | Buy |
| 20-day EMA: | 1.1 | Buy |
| 50-day EMA: | 1.18 | Buy |
| 200-day EMA: | 37.12 | Sell |
AstraZeneca PLC Earnings Growth & AZNCF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.11 per share, and a decrease next year of $0.00 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
AstraZeneca PLC Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals Plc Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||